rotarix oral suspension (oral applicator)
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - suspension - not less than 10⁶ ccid₅₀/dose (1.5 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.5 ml)
rotarix
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - powder, for suspension - not less than 10⁶ ccid₅₀/dose (1.0 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.0 ml)
rotarix oral suspension (tube)
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - suspension - not less than 10⁶ ccid₅₀/dose (1.5 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.5 ml)
rotarix suspension
glaxo smith kline (israel) ltd - live attenuated human rotavirus rix4414 strain - suspension - live attenuated human rotavirus rix4414 strain - rota virus, live attenuated - rota virus, live attenuated - rotarix is indicated for the active immunization of infants from the age of 6 weeks for prevention of gastro-enteritis due to rotavirus infection. in clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of types g1p[8], g2p[4], g3p[8], g4p[8] and g9p[8]. the use of rotarix should be based on official recommendations.
rotarix
glaxosmithkline biologicals s.a. - human rotavirus, live attenuated - immunization; rotavirus infections - vaccines - rotarix is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection.the use of rotarix should be based on official recommendation.
rotarix vaccine live oral suspension 1.5ml tube
glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension
rotarix suspension oral
glaxosmithkline biologicals s.a. - human rotavirus vaccine live - suspension oral - not less than 10^6ccid^50/dose
rotarix suspension oral
glaxosmithkline biologicals s.a. - human rotavirus vaccine live - suspension oral - not less than 10^6ccid^50/dose
rotateq
msd pharma (singapore) pte. ltd. - human-bovine rotavirus g1; human-bovine rotavirus g2; human-bovine rotavirus g3; human-bovine rotavirus g4; human-bovine rotavirus p1 - solution - 2.2 x exponential 6 infectious units - human-bovine rotavirus g1 2.2 x exponential 6 infectious units; human-bovine rotavirus g2 2.8 x exponential 6 infectious units; human-bovine rotavirus g3 2.2 x exponential 6 infectious units; human-bovine rotavirus g4 2.0 x exponential 6 infectious units; human-bovine rotavirus p1 2.3 x exponential 6 infectious units
rotarix suspension
glaxosmithkline inc - rotavirus vaccine (rix4414 strain), live, oral, attenuated (human) - suspension - 1000000ccid50 - rotavirus vaccine (rix4414 strain), live, oral, attenuated (human) 1000000ccid50 - vaccines